Abstract
Clinicians have long lacked guidance on how to appropriately manage transgender patients perioperatively. This chapter aims to provide guidance on the safe management of transgender patients in the preoperative, intraoperative, and postoperative phases of surgical procedures. Understanding how gender transition influences anatomy and physiology is essential for the optimization of surgical outcomes and patient safety. Many parameters differ for cisgender and transgender patients, while others stay similar. As the practice of medicine evolves, implementing guidelines from new data on traditionally understudied patient populations, such as LGBT+ individuals, will translate to improved healthcare outcomes and decreased healthcare disparities in these populations. This chapter will focus specifically on the perioperative considerations for patients undergoing a gender transition, also known as transgender patients or (formerly) known as transsexual patients. This information will also be effective in better caring for patients who were born intersex, as they often have had similar surgical procedures and medical treatments as transgender individuals. Overall, we aim to present a brief analysis of critical physiologic, anatomical, procedural, and pharmacological considerations for transgender patients when they require surgical care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
García-Miguel F, Serrano-Aguilar P, López-Bastida J. Preoperative assessment. Lancet. 2003;362:1749–57.
Pedersen AT. Issues to debate on the Women’s Health Initiative (WHI) study. Epidemiology or randomized clinical trials--time out for hormone replacement therapy studies? Hum Reprod. 2003;18:2241–4.
Streed CG, et al. Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review. Ann Intern Med. 2017;167:256.
Mitchell HK, et al. Prevalence of gender dysphoria and suicidality and self-harm in a national database of paediatric inpatients in the USA: a population-based, serial cross-sectional study. Lancet Child Adolesc Health. 2022;6:876–84.
Tollinche LE, et al. The perioperative care of the transgender patient. Anesth Analg. 2018;127:359–66.
Tollinche LE, Rosa WE, van Rooyen CD. Perioperative considerations for person-centered gender-affirming surgery. Adv Anesth. 2021;39:77–96.
Alzahrani T, et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019;12:e005597.
Van Kesteren PJM, Asscheman H, Megens JAJ, Gooren LJG. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol. 1997;47:337–43.
T’Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. Endocrinology of transgender medicine. Endocr Rev. 2019;40:97–117.
Johnson RL, Hemington-Gorse SJ, Dhital SK. Do cosmetic surgeons consider estrogen-containing drugs to be of significant risk in the development of thromboembolism? Aesthet Plast Surg. 2008;32:743–7.
Berli JU, et al. What surgeons need to know about gender confirmation surgery when providing care for transgender individuals: a review. JAMA Surg. 2017;152:394.
Coleman E, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism. 2012;13:165–232.
Toorians AWFT, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab. 2003;88:5723–9.
Gooren L. Hormone Treatment of the Adult Transsexual Patient. Horm Res Paediatr. 2005;64:31–6.
Arnold JD, Sarkodie EP, Coleman ME, Goldstein DA. Incidence of venous thromboembolism in transgender women receiving oral estradiol. J Sex Med. 2016;13:1773–7.
Wierckx K, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study. Eur J Endocrinol. 2013;169:471–8.
Asscheman H, Gooren LJG, Eklund PLE. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism. 1989;38:869–73.
Asscheman H, et al. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164:635��42.
van Velzen D, et al. Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy. J Clin Endocrinol Metab. 2022;107:e2000–7.
Ozaydin M, et al. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction. Anadolu Kardiyol Derg Anatol J Cardiol. 2010;10:137–42.
Barba-Navarro R, et al. The effect of spironolactone on acute kidney injury after cardiac surgery: a randomized, placebo-controlled trial. Am J Kidney Dis. 2017;69:192–9.
Green NA, Harrison BD. Breathlessness in patients with prostatic carcinoma treated with cyproterone acetate. BMJ. 1989;298:1524.
Mallari R, Sinclair RD. Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia. Int J Dermatol. 2002;41:946–7.
Hochberg Z, Pacak K, Chrousos GP. Endocrine Withdrawal Syndromes. Endocr Rev. 2003;24:523–38.
Brighouse D. Hormone replacement therapy (HRT) and anaesthesia. Br J Anaesth. 2001;86:709–16.
LaVasseur C, et al. Hormonal therapies and venous thrombosis: Considerations for prevention and management. Res Pract Thromb Haemost. 2022;6:e12763.
Gomes MPV, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004;164:1965.
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810.
Hembree WC, et al. Endocrine treatment of transsexual persons:an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:3132–54.
Irwig MS. Cardiovascular health in transgender people. Rev Endocr Metab Disord. 2018;19:243–51.
Boskey ER, Taghinia AH, Ganor O. Association of surgical risk with exogenous hormone use in transgender patients: a systematic review. JAMA Surg. 2019;154:159.
Ali SS, Elliott WH, Bile acids. XLVII. 12alpha-Hydroxylation of precursors of allo bile acids by rabbit liver microsomes. Biochim Biophys Acta. 1975;409:249–57.
Spatz M, Renkawek K, Murray MR, Klatzo I. Uptake of radiolabeled glucose analogues by organotypic pia arachnoid cultures. Brain Res. 1975;100:710–5.
Seal LJ. A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Ann Clin Biochem Int J Lab Med. 2016;53:10–20.
Cervi A, Balitsky AK. Testosterone use causing erythrocytosis. Can Med Assoc J. 2017;189:E1286–8.
Madsen MC, et al. Erythrocytosis in a large cohort of trans men using testosterone: a long-term follow-up study on prevalence, determinants, and exposure years. J Clin Endocrinol Metab. 2021;106:1710–7.
Ederer IA, et al. A single-center 10-year experience of 180 transmasculine patients undergoing gender-affirming mastectomy while continuing masculinizing hormone replacement therapy. Aesthet Plast Surg. 2022;47(3):946–54. https://doi.org/10.1007/s00266-022-03213-x.
Hage JJ, Kanhai RCJ, Oen AL, van Diest PJ, Karim RB. The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals. Plast Reconstr Surg. 2001;107:734–41.
Visnyei K, Samuel M, Heacock L, Cortes JA. Hypercalcemia in a male-to-female transgender patient after body contouring injections: a case report. J Med Case Rep. 2014;8:71.
Chastre J, et al. Acute and latent pneumonitis after subcutaneous injections of silicone in transsexual men. Am Rev Respir Dis. 1987;135:236–40.
Clark RF, Cantrell FL, Pacal A, chen, W. & Betten, D. P. Subcutaneous silicone injection leading to multi-system organ failure. Clin Toxicol. 2008;46:834–7.
Agrawal N, Altiner S, Mezitis NHE, Helbig S. Silicone-induced granuloma after injection for cosmetic purposes: a rare entity of calcitriol-mediated hypercalcemia. Case Rep Med. 2013;2013:1–3.
Coulaud JM, et al. Adult respiratory distress syndrome and silicone injection. Toxicol Eur Res Rech Eur En Toxicol. 1983;5:171–4.
Cumming R, Sylvester K, Fuld J. P257 Understanding the effects on lung function of chest binder use in the transgender population. Thorax. 2016;71:A227.1-A227.
Bockting WO, Miner MH, Swinburne Romine RE, Hamilton A, Coleman ES. Mental health, and resilience in an online sample of the US transgender population. Am J Public Health. 2013;103:943–51.
Hershner S, et al. Associations between transgender identity, sleep, mental health and suicidality among a north american cohort of college students. Nat Sci Sleep. 2021;13:383–98.
Schulman JK, Erickson-Schroth L. Mental health in sexual minority and transgender women. Med Clin North Am. 2019;103:723–33.
Lytle MC, Blosnich JR, Kamen C. The association of multiple identities with self-directed violence and depression among transgender individuals. Suicide Life Threat Behav. 2016;46:535–44.
Nickinson RSJ, Board TN, Kay PR. Post-operative anxiety and depression levels in orthopaedic surgery: a study of 56 patients undergoing hip or knee arthroplasty. J Eval Clin Pract. 2009;15:307–10.
Anderson K, Krakowsky Y, Potter E, Hudson J, Cox AR. Adult transgender care: a review for urologists. Can Urol Assoc J. 2021;15:345.
Pardo J, editor. Miller’s basics of anesthesia / Manuel C. (Elsevier; 2023.
van Klei WA, et al. The value of routine preoperative electrocardiography in predicting myocardial infarction after Noncardiac surgery. Ann Surg. 2007;246:165–70.
Defreyne J, et al. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Andrology. 2018;6:446–54.
SoRelle JA, et al. Impact of hormone therapy on laboratory values in transgender patients. Clin Chem. 2019;65:170–9.
Apfelbaum JL, et al. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology. 2012;116:522–38.
Wierckx K, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27:483–7.
Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124:1120–7.
Obedin-Maliver J, Makadon HJ. Transgender men and pregnancy. Obstet Med. 2016;9:4–8.
Vowles BJ, Ahmad I, Christodoulides G. Unexpected difficult airway management in a transgender female patient. Anaesth Rep. 2020;8:36–9.
Kim H-T. Vocal feminization for transgender women: current strategies and patient perspectives. Int J Gen Med. 2020;13:43–52.
Koçak I, et al. Laser reduction glottoplasty for managing androphonia after failed cricothyroid approximation surgery. J Voice. 2010;24:758–64.
Goddard JC, et al. Feminizing genitoplasty in adult transsexuals: early and long-term surgical results. BJU Int. 2007;100:607–13.
Nolan IT, et al. The role of voice therapy and phonosurgery in transgender vocal feminization. J Craniofac Surg. 2019;30:1368–75.
Saito T, Liu W, Chew STH, Ti LK. Incidence of and risk factors for difficult ventilation via a supraglottic airway device in a population of 14 480 patients from South-East Asia. Anaesthesia. 2015;70:1079–83.
Chiari A, Tobin JR, Pan H-L, Hood DD, Eisenach JC. Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females. Anesthesiology. 1999;91:1447.
Chandrasekhar K, Togioka BM, Jeffers JL. Sugammadex. In: StatPearls. Stat Pearls Publishing; 2022.
Ueno K. Gender differences in pharmacokinetics of anesthetics. Masui. 2009;58:51–8.
Lazorwitz A, Dindinger E, Aguirre N, Sheeder J. Pre- and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital. J Anesth. 2020;34:294–7.
Tsen LC, Arthur GR, Datta S, Hornstein MD, Bader AM. Estrogen-induced changes in protein binding of bupivacaine during in vitro fertilization. Anesthesiology. 1997;87:879–83.
Basaran B, Gundogdu H, Tutar S, Gulerman C. Relationship between serum estrogen concentration and propofol consumption: A prospective observational study of patients undergoing oocyte retrieval: Effects of estrogen on anesthetic need. J Obstet Gynaecol Res. 2019;45:148–55.
Salgado CJ, et al. Combined general and epidural anesthesia is associated with decreased opioid consumption and enhanced pain control after penile inversion vaginoplasty in transwomen. Ann Plast Surg. 2019;83:681–6.
Kukreja P, et al. Sacral erector spinae plane block for gender reassignment surgery. Cureus. 2020;12(4):e7665.
Tollinche LE, Van Rooyen C, Afonso A, Fischer GW, Yeoh CB. Considerations for transgender patients perioperatively. Anesthesiol Clin. 2020;38:311–26.
Pan S, Honig SC. Gender-affirming surgery: current concepts. Curr Urol Rep. 2018;19:62.
Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine: AABB CHOOSING WISELY CAMPAIGN. Transfusion (Paris). 2014;54:2344–52.
Mannheimer B, et al. Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study. Endocrine. 2019;66:660–5.
Fraser CL, Sarnacki P. Na+-K+-ATPase pump function in rat brain synaptosomes is different in males and females. Am J Physiol-Endocrinol Metab. 1989;257:E284–9.
Guerra M, Rodriguez Del Castillo A, Battaner E, Mas M. Androgens stimulate preoptic area Na+,K+-ATPase activity in male rats. Neurosci Lett. 1987;78:97–100.
LaBella FS, et al. Progesterone derivatives that bind to the digitalis receptor: effects on Na+,K+-ATPase and isolated tissues. Fed Proc. 1985;44:2806–11.
Takahashi T, Mizuno J. Factors that increase external pressure to the fibular head region, but not medial region, during use of a knee-crutch/leg-holder system in the lithotomy position. Ther Clin Risk Manag. 2015;11:255. https://doi.org/10.2147/TCRM.S72511.
Bretherton I, et al. Bone microarchitecture in transgender adults: a cross-sectional study. J Bone Miner Res. 2022;37:643–8.
Robertson BD, Lerner BS, Collen JF, Smith PR. The effects of transgender hormone therapy on sleep and breathing: a case series. J Clin Sleep Med. 2019;15:1529–33.
Peitzmeier S, Gardner I, Weinand J, Corbet A, Acevedo K. Health impact of chest binding among transgender adults: a community-engaged, cross-sectional study. Cult Health Sex. 2017;19:64–75.
Schumann R, Polaner DM. Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting. Anesth Analg. 1999;89:796.
Bremner WGM, Kumar CM. Delayed surgical emphysema, pneumomediastinum and bilateral pneumothoraces after postoperative vomiting. Br J Anaesth. 1993;71:296–7.
Apfel CC, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting†. Br J Anaesth. 2012;109:742–53.
Apfel CC, Läärä E, Koivuranta M, Greim C-A, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693.
Gupta A, et al. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: A systematic review of randomized controlled trials. Anesthesiology. 2003;99:488–95.
Büttner M, Walder B, von Elm E, Tramèr MR. Is low-dose haloperidol a useful antiemetic?: A meta-analysis of published and unpublished randomized trials. Anesthesiology. 2004;101:1454–63.
Tornetta FJ. Double-blind evaluation of haloperidol for antiemetic activity. Anesth Analg. 1972;51:964–7.
Brettner F, et al. Gender-specific differences in low-dose haloperidol response for prevention of postoperative nausea and vomiting: a register-based cohort study. PLoS One. 2016;11:e0146746.
Leslie DL, et al. Premature death associated with delirium at 1-year follow-up. Arch Intern Med. 2005;165:1657.
Hewitt J, et al. The prevalence of delirium in an older acute surgical population and its effect on outcome. Geriatrics. 2019;4:57.
Kirfel A, et al. Postoperative delirium is an independent factor influencing the length of stay of elderly patients in the intensive care unit and in hospital. J Anesth. 2022;36:341–8.
Wang H, et al. gender differences and postoperative delirium in adult patients undergoing cardiac valve surgery. Front Cardiovasc Med. 2021;8:751421.
Wei B, et al. Risk factors for emergence agitation in adults after general anesthesia: a systematic review and meta-analysis. Acta Anaesthesiol Scand. 2021;65:719–29.
Hudek K. Emergence delirium: a nursing perspective. AORN J. 2009;89:509–20.
Scott GM, Gold JI. Emergence delirium: a re-emerging interest. Semin Anesth Perioper Med Pain. 2006;25:100–4.
Rim JC, et al. Risk factors of emergence agitation after general anesthesia in adult patients. Anesth Pain Med. 2016;11:410–6.
Tsui SL, et al. The efficacy, applicability and side-effects of postoperative intravenous patient-controlled morphine analgesia: an audit of 1233 Chinese patients. Anaesth Intensive Care. 1996;24:658–64.
Kim H-C, et al. Postanaesthetic emergence agitation in adult patients after general anaesthesia for urological surgery. J Int Med Res. 2015;43:226–35.
Binhas M, Motamed C, Hawajri N, Yiou R, Marty J. Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit. Ann Fr Anesth Réanimation. 2011;30:122–5.
Pisklakov S, Carullo V. Care of the transgender patient: postoperative pain management. Top Pain Manag. 2016;31:1–8.
Stachenfeld NS. Hormonal changes during menopause and the impact on fluid regulation. Reprod Sci. 2014;21:555–61.
Herbst JH, HIV/AIDS Prevention Research Synthesis Team, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the united states: a systematic review. AIDS Behav. 2008;12:1–17.
Goldblum P, et al. The relationship between gender-based victimization and suicide attempts in transgender people. Prof Psychol Res Pract. 2012;43:468–75.
Mepham N, Bouman WP, Arcelus J, Hayter M, Wylie KR. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge. J Sex Med. 2014;11:2995–3001.
James SE, Herman J, Keisling M, Mottet L, Anafi M. 2015 U.S. transgender survey (USTS): version 1; 2019. https://doi.org/10.3886/ICPSR37229.V1.
Nadal KL, Skolnik A, Wong Y. Interpersonal and systemic microaggressions toward transgender people: implications for counseling. J LGBT Issues Couns. 2012;6:55–82.
Garofalo R. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. National Academies Press; 2011. p. 13128. https://doi.org/10.17226/13128.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pajek, S., Verling, S.D., Smaka, T. (2024). Gender Transition: A Consideration for Anesthesia. In: Thaller, S.R., Cohen, M.N. (eds) A Comprehensive Guide to Male Aesthetic and Reconstructive Plastic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-48503-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-48503-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-48502-2
Online ISBN: 978-3-031-48503-9
eBook Packages: MedicineMedicine (R0)